Home » Chemicals » Oligonucleotide Synthesis Market

Oligonucleotide Synthesis Market By Product (Oligonucleotide-based drugs, Synthesized oligonucleotides, Reagents, Equipment) By Application (Therapeutic applications, Research applications, Diagnostic applications) -Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Key Highlights of the Report

The oligonucleotide synthesis market is segmented by product, application, end-user, and region. The synthesized oligonucleotide segment holds the largest market share under the product segment, with the North American region leading the market growth. In the application segment, the therapeutic application segment holds the largest revenue share and is expected to grow quickly during the forecast period. Academic research institutes are the leading segment in terms of the end user.

The oligonucleotide synthesis market has several drivers; increasing adoption of oligonucleotides in diagnostic applications and growing demand for oligonucleotides in the field of gene editing and gene therapy are driving the market growth. However, the market also faces significant challenges, such as high costs associated with oligonucleotide synthesis and limited accessibility for certain end-users.

Nonetheless, the oligonucleotide synthesis market offers significant growth opportunities; there is a significant increase in demand for therapeutic oligonucleotides in the field of precision medicine.

Market Overview

The Oligonucleotide Synthesis Market has witnessed steady growth in recent years and is expected to grow at a CAGR of 16.50% between 2022 and 2030. The market was valued at USD 7.5 billion in 2022 and is expected to reach USD 21.84 billion in 2030.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

What Are the Main Drivers of The Oligonucleotide Synthesis Market?

The Oligonucleotide Synthesis Market is driven by several factors, increasing the adoption of oligonucleotides in diagnostic applications and growing demand for oligonucleotides in gene editing and gene therapy. These factors increase the demand for Oligonucleotide Synthesis, which drives market growth.

What Are the Major Challenges Faced by The Oligonucleotide Synthesis Market?

The Oligonucleotide Synthesis Market also faces several challenges, including high costs associated with oligonucleotide synthesis and limited accessibility for certain end-users.

What Are the Growth Opportunities in The Oligonucleotide Synthesis Market?

The Oligonucleotide Synthesis Market offers significant growth opportunities, and the increase in demand for therapeutic oligonucleotides in the field of precision medicine presents a significant growth opportunity.

Executive Summary

Overview of The Oligonucleotide Synthesis Market

The Oligonucleotide Synthesis Market has been steadily growing in recent years, driven by the increasing adoption of oligonucleotides in diagnostic applications. The growing demand for oligonucleotides in gene editing and gene therapy has increased the demand for oligonucleotide synthesis. A wide range of product types characterizes the market.

Market Definition

The Oligonucleotide Synthesis Market refers to the market for the production and commercialization of synthetic oligonucleotides, which are short DNA or RNA molecules synthesized in laboratories using various chemical methods. Oligonucleotide synthesis is a process that involves the assembly of nucleotides in a specific order to create custom-designed oligonucleotide sequences.

Oligonucleotides find widespread applications in various fields, including molecular biology, genetic research, diagnostics, therapeutics, and biotechnology. They are utilized in polymerase chain reaction (PCR), DNA sequencing, gene synthesis, gene editing (e.g., CRISPR-Cas9), and in vitro diagnostics.

Market Insights

The global demand for Oligonucleotide Synthesis Market was valued at USD 7.5 billion in 2022 and is expected to reach USD 21.84 billion in 2030, growing at a CAGR of 16.50% between 2023 and 2030.
Synthesized oligonucleotides hold the largest market share leading the product segment. The therapeutic application segment holds the largest revenue share in the application segment.
The research end-user segment is expected to post the highest CAGR during the forecast period between 2022-2030.
North American region is fuelling the growth of the Oligonucleotide Synthesis Market with a high revenue share in the global market.
The increasing adoption of oligonucleotides in diagnostic applications and the growing demand for oligonucleotides in gene editing and gene therapy are the major drivers of market growth.
However, the Oligonucleotide Synthesis Market faces challenges due to the high cost associated with oligonucleotide synthesis and limited accessibility for certain end-users.
The increase in demand for therapeutic oligonucleotides in the field of precision medicine provides major growth opportunities to the oleochemicals market.

Segmentation by Product Type

Oligonucleotide synthesis is the chemical synthesis of short fragments of nucleic acids with a defined chemical structure. The synthesized Oligonucleotides segment holds the largest market share.
The oligonucleotide-based drugs also accounted for a significant market share after synthesized oligonucleotides.
The reagents and equipment product holds the rest of the market share.

Segmentation by Application

The therapeutic segment is accounted to hold the largest market share and is expected to exhibit lucrative growth during the forecast period.
The research application is anticipated to grow at a significant rate.
The diagnostic application holds the rest of the market share.

Segmentation by End-User

Oligonucleotide has huge potential in the medical industry, and with the synthesized oligonucleotide gaining traction, the academic research segment will exhibit lucrative growth over the forecast period.
Hospitals, pharmaceuticals, and biotechnology companies hold a significant market share as it is widely used for therapeutic applications.
The Diagnostic laboratories, CROs, and CMOs hold the rest of the market share.

Segmentation by Region

North American region is fuelling the growth of the Oligonucleotide Synthesis Market with a high revenue share in the global market.
Asia Pacific is a rapidly growing market for oligonucleotide synthesis due to factors such as increasing healthcare expenditure.
The rest of the world, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for Oligonucleotide Synthesis Market.

The United States has a strong biotechnology and pharmaceutical industry, which has contributed to its leadership in the oligonucleotide market. Many leading biotech and pharmaceutical companies based in the U.S. are actively involved in the research, development, and commercialization of oligonucleotide-based products. Additionally, the United States has a strong research and academic infrastructure, with renowned universities and institutions conducting cutting-edge research in oligonucleotides. This research ecosystem fosters innovation and drives the development of new applications and technologies in the oligonucleotide market.

South Korea has been making significant strides in the biotechnology field and has the potential to experience growth in the oligonucleotide market. South Korea has invested in research and development, particularly in the biotechnology and pharmaceutical sectors. The country has a strong infrastructure for scientific research, with world-class universities and research institutions actively engaged in oligonucleotide research and development. South Korea has a well-established pharmaceutical industry and a growing biotech sector. These industries have been actively exploring the potential of oligonucleotides for various applications, including therapeutics, diagnostics, and research tools.

Growing Demand For Oligonucleotides In The Field Of Gene Editing And Gene Therapy

Gene editing technologies, such as CRISPR-Cas9, have revolutionized the field of molecular biology and opened up new possibilities for genetic research and therapeutics. Oligonucleotides play a critical role in gene editing by guiding the Cas9 enzyme to specific target sequences in the genome. These oligonucleotides, known as guide RNA (gRNA) or single-stranded DNA (ssDNA) donors, are designed to induce precise changes in the DNA sequence, including gene knockout, gene insertion, or gene correction. The increasing adoption of gene editing techniques and the demand for customized oligonucleotides to support these applications drive the growth of the oligonucleotide synthesis market.

Gene therapy, a field focused on using genetic material to treat diseases, is gaining momentum as a promising approach for various genetic disorders, cancers, and other diseases. Oligonucleotides play a crucial role in gene therapy applications by delivering therapeutic nucleic acids, such as siRNA, antisense oligonucleotides, or mRNA, to target cells. These oligonucleotides can modulate gene expression, inhibit disease-causing proteins, or restore the function of mutated genes. As gene therapy research progresses and clinical trials demonstrate positive results, the demand for custom oligonucleotides for gene therapy purposes increases, stimulating market growth.

Increasing Adoption Of Oligonucleotides In Diagnostic Applications

Molecular diagnostics has transformed the field of diagnostics by enabling the detection, monitoring, and characterization of diseases at the genetic and molecular levels. Oligonucleotides are essential components in various molecular diagnostic techniques, including polymerase chain reaction (PCR), real-time PCR, nucleic acid amplification, and hybridization-based assays. Oligonucleotide probes and primers are used to target specific DNA or RNA sequences associated with diseases, facilitating the identification and quantification of genetic variants, pathogens, and biomarkers. The increasing adoption of molecular diagnostics drives the demand for custom oligonucleotides, fueling the growth of the oligonucleotide synthesis market.

Genetic testing is crucial in understanding inherited diseases, identifying genetic predispositions, and enabling personalized medicine. Oligonucleotides are extensively used in genetic testing methodologies, such as sequencing, genotyping, and mutation analysis. Custom-designed oligonucleotides are employed as probes or primers to target specific gene regions of interest, facilitating the detection of genetic variations, disease-associated mutations, and gene expression profiles. The expanding applications of genetic testing in healthcare and research contribute to the increasing demand for oligonucleotides, thereby driving market growth.

High Cost Associated With Oligonucleotide Synthesis And Limited Accessibility For Certain End-Users

Oligonucleotide synthesis involves complex chemical processes, specialized equipment, and high-quality reagents, which contribute to the overall cost of production. The cost of oligonucleotides can vary based on factors such as length, purity, modifications, and synthesis scale. Longer oligonucleotides or those with specific modifications tend to be more expensive to synthesize. The high cost of oligonucleotide synthesis can be a significant barrier for smaller research laboratories, academic institutions, and emerging biotechnology companies with limited budgets. The affordability of oligonucleotides affects their accessibility and utilization, potentially restraining the market’s growth. While advances in oligonucleotide synthesis techniques have improved scalability, there are still limitations in cost-effectively producing large quantities of high-quality oligonucleotides. The synthesis of long oligonucleotides, large-scale manufacturing, and meeting the demand for high-throughput applications can be challenging and resource-intensive. The limited scalability of production can lead to supply constraints and longer lead times, impacting the availability and affordability of oligonucleotides. This limitation may restrict the market growth, particularly in cases where large quantities of oligonucleotides are required.

Increasing Demand For Therapeutic Oligonucleotides In The Field Of Precision Medicine

Precision medicine aims to provide tailored medical treatments based on an individual’s genetic profile, disease characteristics, and lifestyle factors. Oligonucleotides have gained significant attention as potential therapeutics for precision medicine approaches. They can be used for targeted therapies, such as antisense oligonucleotides, siRNAs, and aptamers, to modulate gene expression, inhibit disease-causing proteins, or deliver therapeutic payloads. The increasing understanding of disease mechanisms at the molecular level and the development of oligonucleotide-based therapeutic strategies create opportunities for synthesizing and commercializing therapeutic oligonucleotides. Gene-based therapies, including gene replacement, gene silencing, and gene editing, hold immense potential for treating genetic disorders, cancers, and other diseases. Oligonucleotides are essential in these therapies as delivery vehicles, guide RNAs, or DNA repair templates. The advancements in gene editing technologies, such as CRISPR-Cas9, and the increasing number of clinical trials for gene-based therapies drive the demand for custom oligonucleotides tailored to specific therapeutic applications. The expanding field of gene-based therapies presents a significant market opportunity for oligonucleotide synthesis.

Competitive Landscape

Key Players

The Oligonucleotide Synthesis Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

THERMO FISHER SCIENTIFIC, INC.
DANAHER CORPORATION
EUROFINS SCIENTIFIC
KANEKA CORPORATION
MERCK KGAA
ALNYLAM PHARMACEUTICALS, INC.
SAREPTA THERAPEUTICS, INC.,
BIOGEN LIMITED
CINVEN
IONIS PHARMACEUTICALS, INC.

In March 2020, Danaher Corporation (U.S.) established IDT China as an official corporate entity to better service its existing customers within the region, reach out to new clients, and make its industry-leading products more accessible.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Summary of Key Findings

The Oligonucleotide Synthesis Market is segmented by product, end-user, application outlook, and region.
The increasing adoption of oligonucleotides in diagnostic applications and the growing demand for oligonucleotides in gene editing and gene therapy are major drivers of the market.
The Oligonucleotide Synthesis Market also faces several challenges, including costs associated with oligonucleotide synthesis and limited accessibility for certain end-users.
North American region is fuelling the growth of the Oligonucleotide Synthesis Market with the highest revenue share.
The synthesized oligonucleotides and therapeutic applications are the leading product and application segments. The research end-user segment is expected to post the highest CAGR during the forecast period between 2022-2030.

Future Outlook

Oligonucleotides have immense potential in therapeutic applications, including gene therapy, RNA interference (RNAi), and antisense therapy.
The shift towards precision medicine, which involves tailoring treatments to individual patients based on their genetic makeup, drives the demand for oligonucleotide synthesis.
Genomics research and genetic engineering are expanding rapidly, leading to a better understanding of genetic diseases, biomarkers, and drug targets.
The oligonucleotide synthesis process is witnessing continuous technological advancements, improving efficiency, scalability, and cost-effectiveness.

Segmentation

By Product

Oligonucleotide-based drugs
Synthesized oligonucleotides
Reagents
Equipment

By Application

Therapeutic applications
Research applications
Diagnostic applications

By End User

Hospitals
Pharmaceutical & biotechnology companies
Diagnostic laboratories
CROs and CMOs
Academic research institutes

By Region

North America
- United States
- Canada
- Mexico
Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Middle East and Africa
- GCC
- South Africa
- Rest of the Middle East and Africa
South America
- Brazil
- Argentina
- Rest of South America

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Oligonucleotide synthesis Market
2.2. Global Oligonucleotide synthesis Market, By Application
2.3. Global Oligonucleotide synthesis Market, By Product
2.4. Global Oligonucleotide synthesis Market, By End-user
2.5. Global Oligonucleotide synthesis Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Oligonucleotide synthesis Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. End-user
3.5.2. Application
3.5.3. Product
3.5.4. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Oligonucleotide synthesis Market, By Product
7.1. Global Oligonucleotide synthesis Market Overview, by Product
7.1.1. Global Oligonucleotide synthesis Market Revenue Share, By Product, 2022 Vs 2030 (in %)
7.2. Oligonucleotide-based drugs
7.2.1. Global Oligonucleotide synthesis Market, By Region, 2017-2030 (US$ Bn)
7.3. Synthesized oligonucleotides
7.3.1. Global Oligonucleotide synthesis Market, By Region, 2017-2030 (US$ Bn)
7.4. Reagents
7.4.1. Global Oligonucleotide synthesis Market, By Region, 2017-2030 (US$ Bn)
7.5. Equipment
7.5.1. Global Oligonucleotide synthesis Market, By Region, 2017-2030 (US$ Bn)

8. Global Oligonucleotide synthesis Market, by Application, 2017-2030 (US$ Bn)
8.1. Global Oligonucleotide synthesis Market Overview, by Application
8.1.1. Global Oligonucleotide synthesis Market, By Application, 2022 vs 2030 (in%)
8.2. Therapeutic Applications
8.2.1. Global Oligonucleotide synthesis Market, By Region, 2017-2030 (US$ Bn)
8.3. Research applications
8.3.1. Global Oligonucleotide synthesis Market, By Region, 2017-2030 (US$ Bn)
8.4. Diagnostic applications
8.4.1. Global Oligonucleotide synthesis Market, By Region, 2017-2030 (US$ Bn)

9. Global Oligonucleotide synthesis Market, By End-user
9.1. Global Oligonucleotide synthesis Market Overview, by End-user
9.1.1. Global Oligonucleotide synthesis Market, By End-user, 2022 vs 2030 (in %)
9.2. Hospitals
9.2.1. Global Oligonucleotide synthesis Market, By Region, 2017-2030 (US$ Bn)
9.3. Pharmaceutical & Biotechnology companies
9.3.1. Global Oligonucleotide synthesis Market, By Region, 2017-2030 (US$ Bn)
9.4. Diagnostic laboratories
9.4.1. Global Oligonucleotide synthesis Market, By Region, 2017-2030 (US$ Bn)
9.5. Academic research institutes
9.5.1. Global Oligonucleotide synthesis Market, By Region, 2017-2030 (US$ Bn)
9.6. CROs and CMOs
9.6.1. Global Oligonucleotide synthesis Market, By Region, 2017-2030 (US$ Bn)

10. Global Oligonucleotide synthesis Market, By Region
10.1. Global Oligonucleotide synthesis Market Overview, by Region
10.1.1. Global Oligonucleotide synthesis Market, By Region, 2022 vs 2030 (in%)
10.2. End-user
10.2.1. Global Oligonucleotide synthesis Market, By End-user, 2017-2030 (US$ Bn)
10.3. Application
10.3.1. Global Oligonucleotide synthesis Market, By Application, 2017-2030 (US$ Bn)
10.4. Product
10.4.1. Global Oligonucleotide synthesis Market, By Product, 2017-2030 (US$ Bn)

11. North America Oligonucleotide synthesis Market Analysis
11.1. North America Oligonucleotide synthesis Market, by End-user, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. North America Oligonucleotide synthesis Market, by Application, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. North America Oligonucleotide synthesis Market, by Product, 2017-2030(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. North America Oligonucleotide synthesis Market, by Country, 2017-2030 (US$ Bn)
11.4.1. North America Oligonucleotide synthesis Market, by Country, 2022 Vs 2030 (in%)
11.4.2. U.S.
11.4.2.1. U.S. Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.2.2. U.S. Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
11.4.2.3. U.S. Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
11.4.2.4. U.S. Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)
11.4.3. Canada
11.4.3.1. Canada Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.3.2. Canada Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
11.4.3.3. Canada Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
11.4.3.4. Canada Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)
11.4.4. Mexico
11.4.4.1. Mexico Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.4.2. Mexico Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
11.4.4.3. Mexico Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
11.4.4.4. Mexico Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)

12. Europe Oligonucleotide synthesis Market Analysis
12.1. Europe Oligonucleotide synthesis Market, by End-user, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Europe Oligonucleotide synthesis Market, by Application, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Europe Oligonucleotide synthesis Market, by Product, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Europe Oligonucleotide synthesis Market, by region, 2017-2030 (US$ Bn)
12.4.1. Europe Oligonucleotide synthesis Market, by Country, 2022 Vs 2030 (in%)
12.4.2. Germany
12.4.2.1. Germany Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.2.2. Germany Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
12.4.2.3. Germany Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
12.4.2.4. Germany Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)
12.4.3. France
12.4.3.1. France Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.3.2. France Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
12.4.3.3. France Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
12.4.3.4. France Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)
12.4.4. UK
12.4.4.1. UK Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.4.2. UK Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
12.4.4.3. UK Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
12.4.4.4. UK Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)
12.4.5. Italy
12.4.5.1. Italy Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.5.2. Italy Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
12.4.5.3. Italy Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
12.4.5.4. Italy Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)
12.4.6. Spain
12.4.6.1. Spain Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.6.2. Spain Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
12.4.6.3. Spain Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
12.4.6.4. Spain Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)
12.4.7. Rest of Europe
12.4.7.1. Rest of Europe Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.7.2. Rest of Europe Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
12.4.7.3. Rest of Europe Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
12.4.7.4. Rest of Europe Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)

13. Asia Pacific Oligonucleotide synthesis Market Analysis
13.1. Asia Pacific Oligonucleotide synthesis Market, by End-user, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Asia Pacific Oligonucleotide synthesis Market, by Application, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Asia Pacific Oligonucleotide synthesis Market, by Product, 2017-2030(US$ Bn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Asia Pacific Oligonucleotide synthesis Market, by Country, 2017-2030 (US$ Bn)
13.4.1. Asia Pacific Oligonucleotide synthesis Market, by Country, 2022 Vs 2030 (in%)
13.4.2. China
13.4.2.1. China Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.2.2. China Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
13.4.2.3. China Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
13.4.2.4. China Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)
13.4.3. Japan
13.4.3.1. Japan Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.3.2. Japan Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
13.4.3.3. Japan Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
13.4.3.4. Japan Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)
13.4.4. India
13.4.4.1. India Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.4.2. India Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
13.4.4.3. India Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
13.4.4.4. India Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)
13.4.5. South Korea
13.4.5.1. South Korea Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.5.2. South Korea Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
13.4.5.3. South Korea Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
13.4.5.4. South Korea Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)
13.4.6. South-East Asia
13.4.6.1. South-East Asia Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.6.2. South-East Asia Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
13.4.6.3. South-East Asia Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
13.4.6.4. South-East Asia Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)
13.4.7. Rest of Asia Pacific
13.4.7.1. Rest of Asia Pacific Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.7.2. Rest of Asia Pacific Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
13.4.7.3. Rest of Asia Pacific Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
13.4.7.4. Rest of Asia Pacific Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)

14. Latin America Oligonucleotide synthesis Market Analysis
14.1. Latin America Oligonucleotide synthesis Market, by End-user, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Latin America Oligonucleotide synthesis Market, by Application, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Latin America Oligonucleotide synthesis Market, by Product, 2017-2030(US$ Bn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Latin America Oligonucleotide synthesis Market, by Country, 2017-2030 (US$ Bn)
14.4.1. Latin America Oligonucleotide synthesis Market, by Country, 2022 Vs 2030 (in%)
14.4.2. Brazil
14.4.2.1. Brazil Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.2.2. Brazil Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
14.4.2.3. Brazil Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
14.4.2.4. Brazil Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)
14.4.3. Argentina
14.4.3.1. Argentina Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.3.2. Argentina Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
14.4.3.3. Argentina Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
14.4.3.4. Argentina Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)
14.4.4. Rest of Latin America
14.4.4.1. Rest of Latin America Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.4.2. Rest of Latin America Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
14.4.4.3. Rest of Latin America Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
14.4.4.4. Rest of Latin America Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)

15. Middle East and Africa Oligonucleotide synthesis Market Analysis
15.1. Middle East and Africa Oligonucleotide synthesis Market, by End-user, 2017-2030(US$ Bn)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Middle East and Africa Oligonucleotide synthesis Market, by Application, 2017-2030(US$ Bn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Middle East and Africa Oligonucleotide synthesis Market, by Product, 2017-2030(US$ Bn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Middle East and Africa Oligonucleotide synthesis Market, by Country, 2017-2030 (US$ Bn)
15.4.1. Middle East and Africa Oligonucleotide synthesis Market, by Country, 2022 Vs 2030 (in%)
15.4.2. GCC Countries
15.4.2.1. GCC Countries Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.2.2. GCC Countries Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
15.4.2.3. GCC Countries Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
15.4.2.4. GCC Countries Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)
15.4.3. South Africa
15.4.3.1. South Africa Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.3.2. South Africa Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
15.4.3.3. South Africa Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
15.4.3.4. South Africa Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)
15.4.4. Rest of Middle East and Africa
15.4.4.1. Rest of Middle East and Africa Oligonucleotide synthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.4.2. Rest of Middle East and Africa Oligonucleotide synthesis, By End-user, 2017-2030 (US$ Bn)
15.4.4.3. Rest of Middle East and Africa Oligonucleotide synthesis, By Application, 2017-2030 (US$ Bn)
15.4.4.4. Rest of Middle East and Africa Oligonucleotide synthesis, By Product, 2017-2030 (US$ Bn)

16. Company Profiles
16.1. THERMO FISHER SCIENTIFIC, INC.
16.1.1. Company Overview
16.1.2. Products/Services Portfolio
16.1.3. Geographical Presence
16.1.4. Financial Summary
16.1.4.1. Market Revenue and Net Profit (2019-2022)
16.1.4.2. Business Segment Revenue Analysis
16.1.4.3. Geographical Revenue Analysis
16.2. DANAHER CORPORATION
16.3. EUROFINS SCIENTIFIC
16.4. KANEKA CORPORATION
16.5. MERCK KGAA
16.6. ALNYLAM PHARMACEUTICALS, INC.
16.7. SAREPTA THERAPEUTICS
16.8. BIOGEN LIMITED
16.9. CINVEN
16.10. IONIS PHARMACEUTICALS, INC.

List of Figures
FIG. 1 Global Oligonucleotide synthesis Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Oligonucleotide synthesis Market Segmentation
FIG. 4 Global Oligonucleotide synthesis Market, by End-user, 2022 (US$ Bn)
FIG. 5 Global Oligonucleotide synthesis Market, by Application, 2022 (US$ Bn)
FIG. 6 Global Oligonucleotide synthesis Market, by Product, 2022 (US$ Bn)
FIG. 7 Global Oligonucleotide synthesis Market, by Geography, 2022 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by End-user, 2022
FIG. 9 Attractive Investment Proposition, by Application, 2022
FIG. 10 Attractive Investment Proposition, by Product, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key Oligonucleotide synthesis Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key Oligonucleotide synthesis Market Manufacturers, 2022
FIG. 14 Global Oligonucleotide synthesis Market Value Contribution, By Product, 2022 & 2030 (Value %)
FIG. 15 Global Oligonucleotide synthesis Market, by Oligonucleotide-based drugs, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Oligonucleotide synthesis Market, by Synthesized oligonucleotides, Value, 2017-2030 (US$ Bn)
FIG. 17 Global Oligonucleotide synthesis Market, by Reagents, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Oligonucleotide synthesis Market, by Equipment, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Oligonucleotide synthesis Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 20 Global Oligonucleotide synthesis Market, by THERAPEUTIC APPLICATIONS, Value, 2017-2030 (US$ Bn)
FIG. 21 Global Oligonucleotide synthesis Market, by Research applications, 2017-2030 (US$ Bn)
FIG. 22 Global Oligonucleotide synthesis Market, by Diagnostic applications, Value, 2017-2030 (US$ Bn)
FIG. 23 Global Oligonucleotide synthesis Market Value Contribution, By End-user, 2022 & 2030 (Value %)
FIG. 24 Global Oligonucleotide synthesis Market, by Hospitals, Value, 2017-2030 (US$ Bn)
FIG. 25 Global Oligonucleotide synthesis Market, by Pharmaceutical & Biotechnology companies, Value, 2017-2030 (US$ Bn)
FIG. 26 Global Oligonucleotide synthesis Market, by Diagnostic laboratories, Value, 2017-2030 (US$ Bn)
FIG. 27 Global Oligonucleotide synthesis Market, by Academic research institutes, Value, 2017-2030 (US$ Bn)
FIG. 28 Global Oligonucleotide synthesis Market, by CROs and CMOs, Value, 2017-2030 (US$ Bn)
FIG. 29 North America Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 30 U.S. Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 31 Canada Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 32 Europe Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 33 Germany Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 34 France Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 35 U.K. Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 36 Italy Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 37 Spain Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 38 Rest of Europe Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 39 Asia Pacific Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 40 China Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 41 Japan Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 42 India Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 43 South Korea Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 44 South-East Asia Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 45 Rest of Asia Pacific Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 46 Latin America Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 47 Brazil Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 48 Mexico Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 49 Rest of Latin America Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 50 Middle East & Africa Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 51 GCC Countries Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 52 South Africa Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)
FIG. 53 Rest of Middle East and Africa Oligonucleotide synthesis Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Oligonucleotide synthesis Market
TABLE 2 Global Oligonucleotide synthesis Market: Market Drivers Impact Analysis
TABLE 3 Global Oligonucleotide synthesis Market: Market Restraints Impact Analysis
TABLE 4 Global Oligonucleotide synthesis Market, by Competitive Benchmarking, 2022
TABLE 5 Global Oligonucleotide synthesis Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Oligonucleotide synthesis Market, by Key Strategies Analysis, 2022
TABLE 7 Global Oligonucleotide synthesis Market, by Oligonucleotide-based drugs, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Oligonucleotide synthesis Market, by Oligonucleotide-based drugs, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Oligonucleotide synthesis Market, by Synthesized oligonucleotides, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Oligonucleotide synthesis Market, by Synthesized oligonucleotides, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Oligonucleotide synthesis Market, by Reagents, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Oligonucleotide synthesis Market, by Reagents, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Oligonucleotide synthesis Market, by Equipment, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Oligonucleotide synthesis Market, by Equipment, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Oligonucleotide synthesis Market, by THERAPEUTIC APPLICATIONS, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Oligonucleotide synthesis Market, by THERAPEUTIC APPLICATIONS, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Oligonucleotide synthesis Market, by Research applications, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Oligonucleotide synthesis Market, by Research applications, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Oligonucleotide synthesis Market, by Diagnostic applications, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Oligonucleotide synthesis Market, by Diagnostic applications, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Oligonucleotide synthesis Market, by Hospitals, By Region, 2017-2022 (US$ Bn)
TABLE 22 Global Oligonucleotide synthesis Market, by Hospitals, By Region, 2023-2030 (US$ Bn)
TABLE 23 Global Oligonucleotide synthesis Market, by Pharmaceutical & Biotechnology companies, By Region, 2017-2022 (US$ Bn)
TABLE 24 Global Oligonucleotide synthesis Market, by Pharmaceutical & Biotechnology companies, By Region, 2023-2030 (US$ Bn)
TABLE 25 Global Oligonucleotide synthesis Market, by Diagnostic laboratories, By Region, 2017-2022 (US$ Bn)
TABLE 26 Global Oligonucleotide synthesis Market, by Diagnostic laboratories, By Region, 2023-2030 (US$ Bn)
TABLE 27 Global Oligonucleotide synthesis Market, by CROs and CMOs, By Region, 2017-2022 (US$ Bn)
TABLE 28 Global Oligonucleotide synthesis Market, by CROs and CMOs, By Region, 2023-2030 (US$ Bn)
TABLE 29 Global Oligonucleotide synthesis Market, by Academic research institutes, By Region, 2017-2022 (US$ Bn)
TABLE 30 Global Oligonucleotide synthesis Market, by Academic research institutes, By Region, 2023-2030 (US$ Bn)
TABLE 31 Global Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 32 Global Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 33 Global Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 34 Global Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 35 Global Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 36 Global Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 37 Global Oligonucleotide synthesis Market, by Region, 2017-2022 (US$ Bn)
TABLE 38 Global Oligonucleotide synthesis Market, by Region, 2023-2030 (US$ Bn)
TABLE 39 North America Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 40 North America Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 41 North America Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 42 North America Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 43 North America Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 44 North America Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 45 North America Oligonucleotide synthesis Market, by Country, 2017-2022 (US$ Bn)
TABLE 46 North America Oligonucleotide synthesis Market, by Country, 2023-2030 (US$ Bn)
TABLE 47 United States Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 48 United States Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 49 United States Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 50 United States Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 51 United States Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 52 United States Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 53 Canada Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 54 Canada Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 55 Canada Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 56 Canada Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 57 Canada Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 58 Canada Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 59 Mexico Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 60 Mexico Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 61 Mexico Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 62 Mexico Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 63 Mexico Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 64 Mexico Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 65 Europe Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 66 Europe Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 67 Europe Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 68 Europe Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 69 Europe Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 70 Europe Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 71 Europe Oligonucleotide synthesis Market, by Country, 2017-2022 (US$ Bn)
TABLE 72 Europe Oligonucleotide synthesis Market, by Country, 2023-2030 (US$ Bn)
TABLE 73 Germany Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 74 Germany Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 75 Germany Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 76 Germany Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 77 Germany Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 78 Germany Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 79 France Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 80 France Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 81 France Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 82 France Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 83 France Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 84 France Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 85 United Kingdom Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 86 United Kingdom Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 87 United Kingdom Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 88 United Kingdom Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 89 United Kingdom Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 90 United Kingdom Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 91 Italy Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 92 Italy Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 93 Italy Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 94 Italy Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 95 Italy Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 96 Italy Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 97 Spain Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 98 Spain Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 99 Spain Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 100 Spain Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 101 Spain Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 102 Spain Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 103 Rest of Europe Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 104 Rest of Europe Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 105 Rest of Europe Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 106 Rest of Europe Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 107 Rest of Europe Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 108 Rest of Europe Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 109 Asia Pacific Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 110 Asia Pacific Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 111 Asia Pacific Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 112 Asia Pacific Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 113 Asia Pacific Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 114 Asia Pacific Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 115 Asia Pacific Oligonucleotide synthesis Market, by Country, 2017-2022 (US$ Bn)
TABLE 116 Asia Pacific Oligonucleotide synthesis Market, by Country, 2023-2030 (US$ Bn)
TABLE 117 China Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 118 China Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 119 China Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 120 China Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 121 China Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 122 China Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 123 Japan Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 124 Japan Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 125 Japan Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 126 Japan Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 127 Japan Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 128 Japan Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 129 India Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 130 India Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 131 India Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 132 India Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 133 India Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 134 India Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 135 South Korea Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 136 South Korea Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 137 South Korea Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 138 South Korea Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 139 South Korea Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 140 South Korea Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 141 South-East Asia Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 142 South-East Asia Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 143 South-East Asia Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 144 South-East Asia Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 145 South-East Asia Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 146 South-East Asia Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 147 Rest of Asia Pacific Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 148 Rest of Asia Pacific Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 149 Rest of Asia Pacific Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 150 Rest of Asia Pacific Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 151 Rest of Asia Pacific Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 152 Rest of Asia Pacific Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 153 Latin America Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 154 Latin America Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 155 Latin America Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 156 Latin America Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 157 Latin America Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 158 Latin America Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 159 Latin America Oligonucleotide synthesis Market, by Country, 2017-2022 (US$ Bn)
TABLE 160 Latin America Oligonucleotide synthesis Market, by Country, 2023-2030 (US$ Bn)
TABLE 161 Brazil Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 162 Brazil Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 163 Brazil Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 164 Brazil Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 165 Brazil Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 166 Brazil Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 167 Argentina Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 168 Argentina Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 169 Argentina Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 170 Argentina Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 171 Argentina Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 172 Argentina Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 173 Rest of Latin America Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 174 Rest of Latin America Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 175 Rest of Latin America Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 176 Rest of Latin America Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 177 Rest of Latin America Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 178 Rest of Latin America Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 179 Middle East and Africa Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 180 Middle East and Africa Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 181 Middle East and Africa Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 182 Middle East and Africa Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 183 Middle East and Africa Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 184 Middle East and Africa Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 185 Middle East and Africa Oligonucleotide synthesis Market, by Country, 2017-2022 (US$ Bn)
TABLE 186 Middle East and Africa Oligonucleotide synthesis Market, by Country, 2023-2030 (US$ Bn)
TABLE 187 GCC Countries Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 188 GCC Countries Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 189 GCC Countries Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 190 GCC Countries Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 191 GCC Countries Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 192 GCC Countries Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 193 South Africa Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 194 South Africa Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 195 South Africa Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 196 South Africa Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 197 South Africa Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 198 South Africa Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)
TABLE 199 Rest of Middle East and Africa Oligonucleotide synthesis Market, by End-user, 2017-2022 (US$ Bn)
TABLE 200 Rest of Middle East and Africa Oligonucleotide synthesis Market, by End-user, 2023-2030 (US$ Bn)
TABLE 201 Rest of Middle East and Africa Oligonucleotide synthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 202 Rest of Middle East and Africa Oligonucleotide synthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 203 Rest of Middle East and Africa Oligonucleotide synthesis Market, by Product, 2017-2022 (US$ Bn)
TABLE 204 Rest of Middle East and Africa Oligonucleotide synthesis Market, by Product, 2023-2030 (US$ Bn)

Frequently Asked Questions

What is the current size of The Oligonucleotide Synthesis Market?

The Oligonucleotide Synthesis Market was valued at USD 7.5 billion in 2022.

What is the expected growth rate of The Oligonucleotide Synthesis Market Between 2023 and 2030?

The Oligonucleotide Synthesis Market is expected to grow at a CAGR of 16.50% between 2023 and 2030, reaching USD 21.84 billion in 2030.

Which segment is leading the market share in terms of product?

Synthesized oligonucleotides are the leading segment in product types, holding a significant share in terms of value.

Which region is fuelling the growth of The Oligonucleotide Synthesis Market?

North American region is fuelling the growth of the Oligonucleotide Synthesis Market, with a significant share in 2022.

Who are the major players in the Oligonucleotide Synthesis Market?

The top players include THERMO FISHER SCIENTIFIC, INC., DANAHER CORPORATION, EUROFINS SCIENTIFIC, KANEKA CORPORATION, MERCK KGAA, ALNYLAM PHARMACEUTICALS, INC., SAREPTA THERAPEUTICS, INC., BIOGEN LIMITED, CINVEN, IONIS PHARMACEUTICALS, INC.

What are the major market drivers of The Oligonucleotide Synthesis Market?

The increasing adoption of oligonucleotides in diagnostic applications and growing demand for oligonucleotides in the field of gene editing and gene therapy are the major drivers of market growth.

What are the major market restraints of The Oligonucleotide Synthesis Market?

Cost associated with oligonucleotide synthesis and limited accessibility for certain end-users is the major market restraints.

What are the major market opportunities of The Oligonucleotide Synthesis Market?

The increase in demand for therapeutic oligonucleotides in precision medicine offers a significant growth opportunity for The Oligonucleotide Synthesis Market.

What segment is leading the market growth in terms of end users?

Academic research institutes are leading the market growth in terms of the end user.

What segment is leading the market growth in terms of application?

Therapeutic application is leading the market growth in terms of application.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –